KALA BIO
KALA
24 hedge funds and large institutions have $5.56M invested in KALA BIO in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
16% more capital invested
Capital invested by funds: $4.81M → $5.56M (+$752K)
14% more funds holding
Funds holding: 21 → 24 (+3)
0.01% more ownership
Funds ownership: 0.31% → 0.32% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$612K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$276K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$255K |
| 4 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
+$151K |
| 5 |
BlackRock
New York
|
+$76.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$227K |
| 2 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$181K |
| 3 |
Jane Street
New York
|
-$35.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$29.5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$13.2K |
KALA Hedge Fund Activity: Q2 2023 in Review
24 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q2 2023, worth a combined $5.56M — up 16% from $4.81M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new KALA positions and 3 closed out — a net gain of 3 holders — while 7 added to existing stakes and 4 trimmed.
The largest buyer was Baker Bros. Advisors, adding an estimated $612K. The largest seller was Millennium Management, cutting an estimated $227K.
- 24 institutional investors held KALA BIO (KALA) as of Q2 2023, up from 21 in Q1 2023.
- Funds reported $5.56M of KALA BIO stock for Q2 2023, up 16% quarter-over-quarter.
- 6 funds opened new KALA BIO positions in Q2 2023 and 3 closed out, a net change of +3 holders.
- The largest KALA BIO buyer in Q2 2023 was Baker Bros. Advisors, an estimated $612K added.
- The largest KALA BIO seller in Q2 2023 was Millennium Management, an estimated $227K sold.
Based on aggregated 13F filings for Q2 2023.